Health
Sabari Stresses the Importance of Molecular Testing in Lung Cancer – OncLive
Joshua K. Sabari, MD, discussed the management of patients with early-stage and metastatic lung cancer, the roles of molecular testing, surgery, staging, and ongoing…
Concurrent tissue- and plasma-based testing is needed in all patients to understand tumor heterogeneity, identify potential de novo resistance mutations, and ensure that existing mutations are not missed by potentially false negative results of liquid biopsy, according to Joshua K. Sabari, MD.
Despite all of our advances in lung cancer, unfortunately this disease is often incurable, explained Sabari. Even in the era of immunotherapy, it is critically important to not forget molecular testing. PD-L1…
-
Noosa News10 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General19 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
Noosa News22 hours agoGirl charged with attempted murder after foster carer stabbed in Ipswich
-
General20 hours agoSharp rise in airfares push UK inflation higher in July